OMICS Group International is all set to organize 3 rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials in Hyderabad. It will be held from October 27-29 this year at Hyderabad International Convention Centre, ... MedIndia, 6 days ago
Hyderabad to host intl. conference on pharmacovigilance & clinical trials from October 27-29 - PharmaBiz, 1 week ago
Promoting Drug Safety through Latest Advancements in Pharmacovigilance - CEOWorld Magazine, 1 month ago
Few FDA officials discuss pharmaceutical regulation these days without reference to how the international reach of the biopharmaceutical industry has altered drug research, production, and regulation. At the annual meeting of the Food and Drug Law ...PharmTech.com, 1 month ago
ALEXION PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
A (Edgar Glimpses Via Acquire Media NewsEdge) Note Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that have been made pursuant to the provisions of the Private Securities Litigation Reform ...TMC Net, 4 weeks ago DYAX CORP - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS TMC Net, 2 weeks ago
Conference Call Scheduled Today at 8:30 a.m. ET ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the second quarter of 2014, including revenue from sales of Iclusig ® (ponatinib). The Company also ...4 Traders, 2 weeks ago ARIAD Reports Second Quarter 2014 Financial Results and Development Progress TMC Net, 2 weeks ago
Hyderabad : 350 Open access journals publisher and 300 plus Scientific Conferences Organiser across the globe, OMICS Group International to organize 3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials in city. It will ...APN News, 1 week ago
| Clinical news and product releases from the past month: The Open Medicine Institute officially launched its OpenMedNet platform, an online healthcare environment that can be used by patients, physicians, and research institutions to track ...Clinical Informatics News, 3 weeks ago
Specific Responsibilities: Registration: Primary contact with national authorities for any regulatory issues regarding Gilead's licences. Liaison with International Regulatory Affairs regarding the preparation of any submissions relating to ...PharmaDiversity, 1 month ago
Biosimilars represent a new class of medicinal products that will have significant impact on clinical use. They are identical on an amino acid sequence level to existing reference biopharmaceutical products (originals). However, they may exhibit ...Swiss Medical Weekly, 1 month ago
on your WebpageAdd Widget >Get your members hooked!